ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway

Zheng, Peng*; Wu, Yaoqin; Wang, Yuqiong; Hu, Fan*wuhan univ sci & technol; 2; inst oceanog 3
Cellular Signalling2023-9DOI: 10.1016/j.cellsig.2023.110771
1被引7阅读
引用收藏
分享

摘要

Disulfiram (DSF) has proven to be a promising anti-tumor drug in preclinical studies. However, its anti-cancer mechanism has not yet been elucidated. As an activator in tumor metastasis, N-myc downstream regulated gene-1 (NDRG1) is involved in multiple oncogenic signaling pathways and is upregulated by cell differentiation signals in various cancer cell lines. DSF treatment results in a significant reduction in NDRG1, while downregulated NDRG1 has a pronounced effect on invading cancer cells, as shown in our previous work. Here, in vitro and in vivo experiments confirm that DSF contributes to regulating tumor growth, EMT, and the migration and invasion of cervical cancer. Furthermore, our results show DSF binds to the ATP-binding pocket in the Nterminal domain of HSP90A, thereby affecting the expression of its client protein NDRG1. To our knowledge, this is the first report of DSF binding to HSP90A. In conclusion, this study sheds light on the molecular mechanism by which DSF inhibits tumor growth and metastasis through the HSP90A/NDRG1/& beta;-catenin pathway in cervical cancer cells. These findings provide novel insights into the mechanism underlying DSF function in cancer cells.

学科与关键词

关键词
DSFNDRG1HSP90AInteractionMolecular dockingSPR
相关
加载中…
  • Quantitative proteomics analysis reveals novel insights into mechanisms of action of disulfiram (DSF)
    Zheng, Peng*; Liu, Chenglinzi; Wu, Yaoqin; Xu, Ruifeng; Chen, Ying; Hu, Fan; Chen, Zhuo*; Zhang, Tongcun*Proteomics Clinical Applications, 2022, 16(1): e2100031.被引 1
  • Disulfiram inhibits liver fibrosis in rats by suppressing hepatic stellate cell activation and viability
    Yang, Xiao-Mei; Wu, Zheng; Wang, Xiaoqi; Zhou, Yaoqi; Zhu, Lei; Li, Dongxue; Nie, Hui-Zhen; Wang, Ya-Hui; Li, Jun*; Ma, Xueyun*BMC Pharmacology & Toxicology, 2022, 23(1): 54.被引 1
  • Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer
    Tang, Bin; Wu, Min; Zhang, Lin; Jian, Shuyi; Lv, Shiyi; Lin, Tongyuan; Zhu, Shuangshuang; Liu, Layang; Wang, Yixue; Yi, Zhengfang*; Jiang, Feiyun*Frontiers in Oncology, 2023, 13: 1154073.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Cellular Signalling
发表日期
2023-09
卷期
第 109 卷
页码
110771
DOI
10.1016/j.cellsig.2023.110771
语言
ENGLISH
成果收录
SCIE
资助标注
Ethics Committee of Wuhan University of Science and Technology, Wuhan China [2022012]; Scientific Research Foundation of Third Institute of Oceanography, MNR [2022012]

作者

  • Z

    Zheng, Peng (通讯) (第一作者)

    wuhan univ sci & technol · 2

  • W

    Wu, Yaoqin

    wuhan univ sci & technol

查看全部 4 位作者收起作者
  • W

    Wang, Yuqiong

    wuhan univ sci & technol

  • H

    Hu, Fan (通讯)

    inst oceanog 3

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417